[PDF][PDF] Optimizing sgRNA to improve CRISPR/Cas9 knockout efficiency: special focus on human and animal cell
S Shojaei Baghini, ZR Gardanova, AO Zekiy… - … in Bioengineering and …, 2021 - frontiersin.org
During recent years, clustered regularly interspaced short palindromic repeat
(CRISPR)/CRISPR-associated protein 9 (Cas9) technologies have been noticed as a rapidly …
(CRISPR)/CRISPR-associated protein 9 (Cas9) technologies have been noticed as a rapidly …
[HTML][HTML] LINK-A: unveiling its functional role and clinical significance in human tumors
B Liao, J Wang, Y Xie, H Luo, J Min - Frontiers in Cell and …, 2024 - frontiersin.org
LINK-A, also recognized as LINC01139, has emerged as a key oncological lncRNA in
cancer. LINK-A is upregulated in solid and liquid tumor samples, including breast cancer …
cancer. LINK-A is upregulated in solid and liquid tumor samples, including breast cancer …
[HTML][HTML] Long Noncoding RNAs in Ovarian Cancer—Functions and Clinical Applications
L Zhong, X Li, Y Wang, B Liu, X Ding… - Frontiers in Bioscience …, 2023 - imrpress.com
Long noncoding RNAs (lncRNAs) are RNA molecules with a length of more than 200 nt that
have been discovered in recent years. LncRNAs can participate in regulating gene …
have been discovered in recent years. LncRNAs can participate in regulating gene …
CRISPR/Cas9: A Molecular Tool for Ovarian Cancer Management beyond Gene Editing
S Dholariya, D Parchwani, M Radadiya… - Critical Reviews™ in …, 2022 - dl.begellhouse.com
Ovarian cancer manifests with early metastases and has an adverse outcome, impacting the
health of women globally. Currently, this malignancy is often treated with cytoreductive …
health of women globally. Currently, this malignancy is often treated with cytoreductive …